Non-alcoholic steatohepatitis (NASH) real-world evidence innovation further extends Verantos’ lead in artificial intelligence for cardiometabolic conditions

Technology enables accurate identification of relevant concepts from routinely collected data PALO ALTO, Calif., Nov. 13, 2023 /PRNewswire/ — Verantos, the global leader in high-validity real-world evidence at scale, today announced the presentation of an abstract on the use of…

Click here to view original post